KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Free Cash Flow (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Free Cash Flow for 16 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 1047.9% to $10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.1 million, a 286.53% increase, with the full-year FY2025 number at $20.1 million, up 286.53% from a year prior.
  • Free Cash Flow was $10.1 million for Q4 2025 at Biolife Solutions, up from $974000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $10.1 million in Q4 2025 to a low of -$12.1 million in Q2 2021.
  • A 5-year average of -$64700.0 and a median of $928500.0 in 2024 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: skyrocketed 1457.36% in 2022, then plummeted 7104.76% in 2023.
  • Biolife Solutions' Free Cash Flow stood at -$666000.0 in 2021, then surged by 1457.36% to $9.0 million in 2022, then plummeted by 33.45% to $6.0 million in 2023, then tumbled by 85.32% to $883000.0 in 2024, then surged by 1047.9% to $10.1 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Free Cash Flow are $10.1 million (Q4 2025), $974000.0 (Q3 2025), and $7.5 million (Q2 2025).